The permeability of gadolinium and the morphology of breast cancers can reliably predict whether those tumors will benefit from neoadjuvant chemotherapy, according to a study by researchers at Duke University.
The permeability of gadolinium and the morphology of breast cancers can reliably predict whether those tumors will benefit from neoadjuvant chemotherapy, according to a study by researchers at Duke University.
The vascularity of tumors and their reaction to blood-borne contrast predict a likely response to therapy. Tumors that were closely packed with cancer cells did not effectively retain contrast and were resistant to chemotherapy, said Oana Craciunescu, Ph.D., a Duke radiation oncologist, who reported the study results at the San Antonio Breast Cancer Symposium in December.
Tumors in which the blood vessels formed a ring pattern around the center were also resistant to chemotherapy because collapsed blood vessels in the center would not carry the drug there. The best responders were homogeneous tumors in which blood vessels were evenly distributed throughout the tumor.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.